Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.
STAT Plus: Class action suit over UnitedHealth’s AI care denials nears key moment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results